FLNA:BMV
Filana Therapeutics Inc
15,92 MXN
0,00%
(0,00) 1 zi
5 oct., 12:05:31 GMT-6 · MXN
search
Toate simbolurile
| Simbol | Preț | Modificare | Modificare % |
|---|
insights_autoSe generează principalele statistici pentru FLNA...
Capitalizarea bursieră
34,97 mil.
Volum mediu
0,00
Volum
0,00
Prețul ridicat pe 52 de săptămâni
56,00 MXN
Prețul redus pe 52 de săptămâni
15,92 MXN
Nr. de angajați
19
Capitalizarea bursieră
34,97 mil.
Volum mediu
0,00
Volum
0,00
Prețul ridicat pe 52 de săptămâni
56,00 MXN
Prețul redus pe 52 de săptămâni
15,92 MXN
Nr. de angajați
19
Subiecte de știri
Din surse web și de la parteneri de știri
Ziare.com
·
acum 18 ore
Pentru a doua oară în istorie: Bursa transmite un semnal de avertizare rar și indică apariția unor...
Simply Wall Street
·
acum 1 oră
Palo Alto Networks (PANW) Becomes Founding Partner In Critical Infrastructure Defense Program
巴士的報
·
acum 46 de minute
Oracle NetSuite Announces Launch of AI-first QuickStart: NYSE Content Update
24/7 Wall St.
·
acum 49 de minute
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Despre Filana Therapeutics Inc
Director executiv-
Angajați19
Înființată la1998
SediuAustin, Texas, Statele Unite ale Americii
Domeniu-
Sitepaintrials.com